Arg689
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9
Powered by Cell Signaling Technology
Home > Mono-methylation Site Page: > Arg689  -  eIF4G (mouse)

Site Information
LSNRGPPrGGPGGEL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 6009525

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 )
Relevant cell line - cell type - tissue:
'brain, embryonic' ( 31 ) , brain ( 2 , 3 , 4 , 5 , 6 , 30 ) , embryo ( 2 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 ) , heart ( 32 ) , kidney ( 19 , 21 ) , lung ( 20 , 22 ) , MEF (fibroblast) ( 23 , 24 , 25 , 26 )

References 

1

Hsu JH, et al. (2017) PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer. Cancer Res 77, 4613-4625
28655788   Curated Info

2

Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87
24129315   Curated Info

3

Guo A (2013) CST Curation Set: 18333; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -;
Curated Info

4

Guo A (2013) CST Curation Set: 18334; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -;
Curated Info

5

Guo A (2013) CST Curation Set: 18336; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -;
Curated Info

6

Guo A (2013) CST Curation Set: 18337; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -;
Curated Info

7

Guo A (2013) CST Curation Set: 18338; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

8

Guo A (2013) CST Curation Set: 18339; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

9

Guo A (2013) CST Curation Set: 18340; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

10

Guo A (2013) CST Curation Set: 18341; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

11

Guo A (2013) CST Curation Set: 18342; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

12

Guo A (2013) CST Curation Set: 18344; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

13

Guo A (2013) CST Curation Set: 18345; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

14

Guo A (2013) CST Curation Set: 18346; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

15

Guo A (2013) CST Curation Set: 18347; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

16

Guo A (2013) CST Curation Set: 18348; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

17

Guo A (2013) CST Curation Set: 18349; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

18

Zhou J (2010) CST Curation Set: 9110; Year: 2010; Biosample/Treatment: cell line, ES J1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

19

Zhou J (2009) CST Curation Set: 7948; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

20

Zhou J (2009) CST Curation Set: 7946; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

21

Zhou J (2009) CST Curation Set: 7947; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

22

Zhou J (2009) CST Curation Set: 7945; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

23

Zhou J (2009) CST Curation Set: 6011; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

24

Zhou J (2009) CST Curation Set: 6009; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

25

Zhou J (2009) CST Curation Set: 6008; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

26

Zhou J (2009) CST Curation Set: 6014; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

27

Rikova K (2008) CST Curation Set: 4939; Year: 2008; Biosample/Treatment: cell line, Dana Farber-S1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

28

Rikova K (2008) CST Curation Set: 4937; Year: 2008; Biosample/Treatment: cell line, Dana Farber-L1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

29

Rikova K (2008) CST Curation Set: 4938; Year: 2008; Biosample/Treatment: cell line, Dana Farber-L2/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

30

Zhou J (2008) CST Curation Set: 3811; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

31

Zhou J (2008) CST Curation Set: 3812; Year: 2008; Biosample/Treatment: tissue, brain, embryonic/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

32

Zhou J (2008) CST Curation Set: 3813; Year: 2008; Biosample/Treatment: tissue, heart/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info